Skip to main content
Premium Trial:

Request an Annual Quote

Immucor Buying Femtoarrays Developer Sentilus

NEW YORK (GenomeWeb) – Transfusion and transplantation diagnostics firm Immucor announced on Wednesday its acquisition of Sentilus for an undisclosed amount.

Durham, NC-based Sentilus was founded in 2012 and is developing an inkjet-printed antibody microarray-based technology called Femtoarrays for use in in vitro diagnostics, including transfusion diagnostics.

Immucor President and CEO William Hawkins said that the Femtoarrays technology "will underpin a full complement of next-generation immunohematology assays. Additionally, we believe the technology has the potential for broad application throughout in vitro diagnostics."

Immucor is headquartered in Norcross, Ga. In May, the US Food and Drug Administration approved the Immucor Precise Type Human Erythrocyte Antigen Molecular BeadChip Test for blood compatibility determination.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.